Quantification of alternative splicing variants of human telomerase reverse transcriptase and correlations with telomerase activity in lung cancer

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Liu, Yan ^a   Wu, Bing quan ^a   Zhong, Hao hao ^a   Tian, Xin xia ^a   Fang, Wei gang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ALTERNATIVE RNA SPLICING; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; GENE DELETION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; LUNG CARCINOMA; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MOLECULAR BEACON; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION;

ADULT; AGED; ALTERNATIVE SPLICING; CELL LINE, TUMOR; ENZYME ACTIVATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RNA ISOFORMS; TELOMERASE;

EID: 84862503099     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038868     Document Type: Article

References (30)

1. Hisatomi H, Ohyashiki K, Ohyashiki JH, Nagao K, Kanamaru K, et al. (2003) Expression profile of a γ-Deletion variant of the human telomerase reverse transcriptase gene. Neoplasia 5: 193-197.
2. Colgin LM, Wilkinson C, Englezou A, Kilian A, Robinson MO, et al. (2000) The hTERT α splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia 2: 426-432.
3. Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR, (2001) Tissue-specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development. Int J Cancer 91: 644-649.
4. Wick M, Zubov D, Hagen G, (1999) Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene 232: 97-106.
5. Lantuejoul S, Soria JC, Moro-Sibilot D, Morat L, Veyrenc S, et al. (2004) Differential expression of telomerase reverse transcriptase (hTERT) in lung tumors. Br J Cancer 90: 1222-1229.
6. Marchetti A, Pellegrini C, Buttitta F, Falleni M, Romagnoli S, et al. (2002) Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation. Lab Invest 82: 729-736.
7. Wang L, Soria JC, Kemp BL, Liu DD, Mao L, et al. (2002) hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer. Clin Cancer Res 8: 2883-2889.
8. Wu TC, Lin P, Hsu C, Huang Y, Chen C, et al. (2003) Loss of telomerase activity may be a potential favorable prognostic marker in lung carcinomas. Lung Cancer 41: 163-169.
9. Liu Y, Wu BQ, Zhong HH, Xu ML, Fang WG, (2010) Detection of telomerase activity in cultured cells and tumor tissue of lung carcinoma by modified telomeric repeat amplification protocol. Pathol Int 60: 386-394.
10. Bradford MM, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 77: 248-254.
11. Piotrowska K, Kleideiter E, Mürdter TE, Taetz S, Baldes C, et al. (2005) Optimization of the TRAP assay to evaluate specificity of telomerase inhibitors. Lab Invest 85: 1565-1569.
12. Taveau M, Stockholm D, Spencer M, Richard I, (2002) Quantification of splice variants using molecular beacon or scorpion primers. Anal Biochem 305: 227-235.
13. Hartmann U, Brümmendorf T, Balabanov S, Thiede C, Illme T, et al. (2005) Telomere length and hTERT expression in patients with acute myeloid leukemia correlates with chromosomal abnormalities. Haematologica 90: 307-316.
14. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, et al. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015.
15. Hou M, Xu D, Björkholm M, Gruber A, (2001) Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity. Clin Chem 47: 519-524.
16. McGruder BM, Atha DH, Wang W, Huppi K, Wei WQ, et al. (2006) Real-time telomerase assay of less-invasively collected esophageal cell samples. Cancer Lett 244: 91-100.
17. Elmore LW, Forsythe HL, Ferreira-Gonzalez A, Garrett CT, Clark GM, et al. (2002) Real-time quantitative analysis of telomerase activity in breast tumor specimens using a highly specific and sensitive fluorescent-based assay. Diagn Mol Pathol 11: 177-185.
18. Fujiwara M, Okayasu I, Takemura T, Tanaka I, Masuda R, et al. (2000) Telomerase activity significantly correlates with chromosome alterations, cell differentiation, and proliferation in lung adenocarcinoma. Mod Pathol 13: 723-729.
19. Ohmura Y, Aoe M, Andou A, Shimizu N, (2000) Telomerase activity and Bcl-2 expression in non-small cell lung cancer. Clin Cancer Res 6: 2980-2987.
20. Maniwa Y, Yoshimura M, Obayashi C, Inaba M, Kiyooka K, et al. (2001) Association of p53 gene mutation and telomerase activity in resectable non-small cell lung cancer. Chest 120: 589-594.
21. Wang J, Liu X, Jiang W, Liang L, (2000) Telomerase activity and expression of the telomerase catalytic subunit gene in non-small cell lung cancer: correlation with decreased apoptosis and clinical prognosis. Chin Med J (Engl) 113: 985-990.
22. Xu JH, Wang YC, Geng X, Li YY, Zhang WM, (2009) Changes of the alternative splicing variants of human telomerase reverse transcriptase during gastric carcinogenesis. Pathobiology 76: 23-29.
23. Wang Y, Kowalski J, Tsai HL, Marik R, Prasad N, et al. (2008) Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasms. Thyroid 18: 1055-1063.
24. Rha SY, Jeung HC, Park KH, Kim JJ, Chung HC, (2009) Changes of telomerase activity by alternative splicing of full-length and beta variants of hTERT in breast cancer patients. Oncol Res 18: 213-220.
25. Lincz LF, Mudge LM, Scorgie FE, Sakoff JA, Hamilton CS, et al. (2008) Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variant. Neoplasia 10: 1131-1137.
26. Mavrogiannou E, Strati A, Stathopoulou A, Tsaroucha EG, Kaklamanis L, et al. (2007) Real-time RT-PCR quantification of human telomerase reverse transcriptase splice variants in tumor cell lines and non-small cell lung cancer. Clin Chem 53: 53-61.
27. Yi X, Shay JW, Wright WE, (2001) Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acids Res 29: 4818-4825.
28. Saebøe-Larssen S, Fossberg E, Gaudernack G, (2006) Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues. BMC Mol Biol 7: 26.
29. Büchler P, Conejo-Garcia JR, Lehmann G, Müller M, Emrich T, et al. (2001) Real-time quantitative PCR of telomerase mRNA is useful for the differentiation of benign and malignant pancreatic disorders. Pancreas 22: 331-340.
30. Hara T, Noma T, Yamashiro Y, Naito K, Nakazawa A, (2001) Quantitative analysis of telomerase activity and telomerase reverse transcriptase expression in renal cell carcinoma. Urol Res 29: 1-6.